Endotoxin Challenge Causes a Proinflammatory State in Obstructive Jaundice

REFERENCES

• Cainzos M, Alcalde JA, Potel J, Puente JL. Hyperbilirubinemia, jaundice and anergy. Hepato-Gastroenterology. 1992;39:330–332.
   PubMedGoogle Scholar
• Regan MC, Keane RM, Little D, Bouchier-Hayes D. Postoperative immunological function and jaundice. Br J Surg. 1994;81:271–273.
   PubMedGoogle Scholar
• Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res. 1994;57:316–336.
   PubMed Web of Science ®Google Scholar
• Armstorng CP, Dixom JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg. 1984;71:234–238.
   PubMedGoogle Scholar
• Trede M, Schwall G. The complications of pancreatectomy. Ann Surg. 1988;207:39–47.
   PubMed Web of Science ®Google Scholar
• Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice caused by endotoxin. A study with germfree rats. Gastroenterology 1990;98:478–485.
   PubMed Web of Science ®Google Scholar
• Clements WDB, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut. 1998;42:293–299.
   PubMedGoogle Scholar
• Kimmings AN, vanDeventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut. 2000;46:725–731.
   PubMed Web of Science ®Google Scholar
• Roughneen PT, Kumar SC, Pellis NR, Rowlands BJ. Endotoxaemia and cholestasis. Surg Gynaecol Obstet. 1988;167:205–210.
   Google Scholar
• Bemelmans MHA, Greve JW, Gouma DJ, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology. 1992;15:1132–1136.
   PubMed Web of Science ®Google Scholar
• Kennedy JA, Lewis H, Clements WDB, Kirk SJ, Campbell G, Halliday MI, Rowlands BJ. Kupffer cell blockade, tumor necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg. 1999;86:1410–1414.
   PubMedGoogle Scholar
• Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC, Harken AH. Therapeutic implications of interleukin-10 in surgical disease. Shock. 1998;10:309–318.
   PubMedGoogle Scholar
• Knolle P, Schlaak J, Uhrig A, Kempf P, Büschenfelde KHM, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol. 1995;22:226–229.
   PubMed Web of Science ®Google Scholar
• Curran RD, Billiar TR, West MA, Benz BG, Simmons RL. Effect of interleukin 2 on Kupffer cell activation. Arch Surg. 1988;123:1373–1378.
   PubMed Web of Science ®Google Scholar
• Wong LK, Ridinger DN, Bandhauer M, Ward JH, Samlowski WE, Iverius P, Pritchard H, Wilson DE. Acute dyslipoproteinemia induced by interleukin-2: Lecithin: cholesteryl aceltransferase, lipoprotein lipase, and hepatic lipase deficiencies. J Clinl Endocr Metab. 1997;82:1572–1581.
   PubMedGoogle Scholar
• Applied Research Ethics National Association/Office of Laboratory Animal Welfare. Institutional Animal Care and Use Committee Guidebook. 2nd ed. Bethesda, MD: National Institutes of Health; 2002.
   Google Scholar
• Yorganci K, Sayek I, Ismailoglu B, Sahin-Erdemli I. Detrimental effect of nitric oxide on mesenteric circulation during endotoxaemia and its reversal with aminoguanidine. Eur J Surg. 2000;166:888–893.
   PubMedGoogle Scholar
• Baykal A, Kaynaroglu V, Hascelik G, Sayek I, Sanac Y. Epinephrine and endotoxin tolerance differentially modulate serum cytokine levels to high-dose lipopolysaccharide challenge in a murine model. Surgery. 1999;125:403–410.
   PubMedGoogle Scholar
• Rola-Pleszcynski M, Hensen SA, Vincent MM, Bellanti JA. Inhibitory effects of bilirubin on cellular immune responses in man. J Pediatr. 1975;42:690–696.
   Google Scholar
• Rubaltelli FF, Granati B, Fortunato A, Piovesan A, Casara G, Colleselli P, Semenzato G. Inhibitory effects of bilirubin and photobilirubin on neonatal and adult T lymphocytes and granulocytes. Biol Neonate. 1982;42:152–158.
   PubMedGoogle Scholar
• Fargion SR, Podda M, Cappellini MD, Fiorelli G. Cellular immunity in intra- and extra-hepatic cholestasis. Minerva Gastroenterol. 1976;22:261–265.
   PubMedGoogle Scholar
• Scott-Conner CE, Grogan JB. Serum and cellular factors in murine obstructive jaundice. Surgery. 1994;15:77–84.
   Google Scholar
• Roughneen PT, Drath DB, Kulkarni AD. Impaired nonspecific cellular immunity in experimental cholestasis. Ann Surg. 1987;206:578–582.
   PubMedGoogle Scholar
• Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ. Impaired cell mediated immunity in experimental biliary obstruction. J Surg Res. 1986;41:113–125.
   PubMed Web of Science ®Google Scholar
• Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ. Suppression of host versus graft response in experimental biliary obstruction. Transplantation. 1986;42:687–689.
   PubMedGoogle Scholar
• Tanaka N, Ryden S, Bergqvist L, Christensen P, Bengmark S. Reticulo-endothelial function in rats with obstructive jaundice. Br J Surg. 1985;72:946–949.
   PubMedGoogle Scholar
• Anand AC, Irshad M, Acharya SK, Gandhi BM, Joshi YK, Tandon BN. Fibronectin in acute and subacute hepatic failure. J Clin Gastroenterol. 1989;11:314–319.
   PubMedGoogle Scholar
• Wyke RJ, Rajkovich IA, Eddleson AL, Williams R. Defective opsonization and complement deficiency in serum from patients with fulminant hepatic failure. Gut. 1980;21:643–649.
   PubMed Web of Science ®Google Scholar
• Welsh FKS, Ramsden CW, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, Reynolds JV. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann Surg. 1998;227:205–212.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503–508.
   PubMed Web of Science ®Google Scholar
• Kimmings AN, Deventer SJ, Rauws EAJ, Huibregste K, Gouma DJ. Systemic inflammatory response in acute cholangitis and after subsequent treatment. Eur J Surg. 2000;166:700–705.
   PubMedGoogle Scholar
• Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; Soluble TNF receptors as prognostic factors for mortality. Gut. 1996;38:447–453.
   PubMed Web of Science ®Google Scholar
• Fink MP. The role of cytokines as mediators of the inflammatory response. In: Townsend CM, ed., Sabiston Textbook of Surgery. 16th ed. Philadelphia: W. B. Saunders; 2001:28–43.
   Google Scholar
• Niedhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863–870.
   PubMedGoogle Scholar
• Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma. 1996;40:613–616.
   PubMedGoogle Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
   PubMed Web of Science ®Google Scholar
• Taga K, Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J Immunol. 1992;148:1143–1148.
   PubMed Web of Science ®Google Scholar
• Lin E, Lowry SF, Calvano SE. The systemic response to injury. In: Schwartz SI, ed., Principles of Surgery. 7th ed. New York: McGraw-Hill; 1999:3–51.
   Google Scholar
• Wahl SM, McCartney-Francis N, Hunt DA, Smith PD, Wahl LM, Katona IM. Monocyte interleukin receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol. 1987;139:1342–1347.
   PubMed Web of Science ®Google Scholar